Transgene SATransgene SATransgene SA

Transgene SA

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪168.17 M‬EUR
−0.280EUR
‪−33.97 M‬EUR
‪35.00 K‬EUR
‪35.29 M‬
Beta (1Y)
−0.03
Employees (FY)
165
Change (1Y)
+7 +4.43%
Revenue / Employee (1Y)
212.12EUR
Net income / Employee (1Y)
‪−205.88 K‬EUR

About Transgene SA


CEO
Alessandro Riva
Headquarters
Strasbourg
Founded
1979
ISIN
FR0005175080
FIGI
BBG000BPCWG0
Transgene SA is a biotechnology company that focuses on designing and developing targeted immunotherapies for the treatment of cancer. Its products include TG4001, TG4050, TG6002, BT-001 & TG6050. The company was founded in December 1979 and is headquartered in Strasbourg, France.

Check out other big names from the same industry as TNG.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TNG is 1.270 EUR — it has decreased by −3.05% in the past 24 hours. Watch Transgene SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Transgene SA stocks are traded under the ticker TNG.
TNG stock has risen by 4.96% compared to the previous week, the month change is a −5.93% fall, over the last year Transgene SA has showed a 48.02% increase.
We've gathered analysts' opinions on Transgene SA future price: according to them, TNG price has a max estimate of 2.00 EUR and a min estimate of 1.60 EUR. Watch TNG chart and read a more detailed Transgene SA stock forecast: see what analysts think of Transgene SA and suggest that you do with its stocks.
TNG reached its all-time high on Mar 7, 2000 with the price of 100.835 EUR, and its all-time low was 0.010 EUR and was reached on Jan 7, 2003. View more price dynamics on TNG chart.
See other stocks reaching their highest and lowest prices.
TNG stock is 4.80% volatile and has beta coefficient of −0.03. Track Transgene SA stock price on the chart and check out the list of the most volatile stocks — is Transgene SA there?
Today Transgene SA has the market capitalization of ‪168.14 M‬, it has increased by 2.06% over the last week.
Yes, you can track Transgene SA financials in yearly and quarterly reports right on TradingView.
Transgene SA is going to release the next earnings report on Mar 18, 2026. Keep track of upcoming events with our Earnings Calendar.
TNG net income for the last half-year is ‪−19.30 M‬ EUR, while the previous report showed ‪−17.49 M‬ EUR of net income which accounts for −10.35% change. Track more Transgene SA financial stats to get the full picture.
No, TNG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2025, the company has 165 employees. See our rating of the largest employees — is Transgene SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Transgene SA EBITDA is ‪−42.20 M‬ EUR, and current EBITDA margin is ‪−116.15 K‬%. See more stats in Transgene SA financial statements.
Like other stocks, TNG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Transgene SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Transgene SA technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Transgene SA stock shows the neutral signal. See more of Transgene SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.